
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $6.9B | $6.6B | $8B | $8.2B | $7.8B | |
Revenue Growth (YoY) | 6.38% | -3.74% | 20.67% | 2.53% | -5.23% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.3B | $2.3B | $2.8B | $3B | $3B | |
Other Inc / (Exp) | $4M | $10M | $9M | $28M | $18M | |
Operating Expenses | $2.3B | $2.3B | $2.8B | $2.4B | $2.8B | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $1.3B | $3B | $2.7B | $2B | $1.9B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $241M | $658M | $582M | $422M | $379M | |
Net Income to Company | $1.1B | $2.3B | $2.1B | $1.6B | $1.5B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.1B | $2.3B | $2.1B | $1.6B | $1.5B | |
Basic EPS (Cont. Ops) | $2.22 | $5.18 | $4.12 | $3.14 | $3.05 | |
Diluted EPS (Cont. Ops) | $2.22 | $5.16 | $4.10 | $3.13 | $3.03 | |
Weighted Average Basic Share | $427.1M | $425.7M | $476M | $475.1M | $450.7M | |
Weighted Average Diluted Share | $428.2M | $427.4M | $477.8M | $476.7M | $453.5M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $2.1B | $3.3B | $3.7B | $6B | $6.4B | |
Revenue (Reported) | $6.9B | $6.6B | $8B | $8.2B | $7.8B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $2.1B | $3.3B | $3.7B | $6B | $6.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $1.6B | $2.1B | $2B | $1.9B | |
Revenue Growth (YoY) | 0.06% | -0.78% | 29.36% | -7.94% | -1.23% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $582M | $640M | $732M | $802M | $774M | |
Other Inc / (Exp) | $3M | $4M | $5M | $5M | $7M | |
Operating Expenses | $583M | $603M | $666M | $720M | $774M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $781M | $536M | $664M | $430M | $468M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $170M | $116M | $153M | $96M | $95M | |
Net Income to Company | $611M | $420M | $511M | $334M | $373M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $611M | $420M | $511M | $334M | $373M | |
Basic EPS (Cont. Ops) | $1.38 | $0.94 | $1.00 | $0.66 | $0.78 | |
Diluted EPS (Cont. Ops) | $1.37 | $0.93 | $1.00 | $0.65 | $0.77 | |
Weighted Average Basic Share | $426M | $422.4M | $485.4M | $461.4M | $438.3M | |
Weighted Average Diluted Share | $427.9M | $424.7M | $487.7M | $463.8M | $442.2M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $880M | $602M | $1.4B | $1.6B | $1.4B | |
Revenue (Reported) | $1.7B | $1.6B | $2.1B | $2B | $1.9B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $880M | $602M | $1.4B | $1.6B | $1.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $6.9B | $6.6B | $8.5B | $8.1B | $7.8B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.3B | $2.4B | $2.9B | $3B | $3B | |
Other Inc / (Exp) | $7M | $11M | $10M | $28M | $20M | |
Operating Expenses | $2.3B | $2.3B | $2.7B | $2.5B | $2.9B | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $2B | $2.7B | $2.8B | $1.8B | $1.9B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $400M | $604M | $619M | $365M | $378M | |
Net Income to Company | $1.6B | $2.1B | $2.2B | $1.4B | $1.5B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.6B | $2.1B | $2.2B | $1.4B | $1.5B | |
Basic EPS (Cont. Ops) | $3.58 | $4.74 | $4.17 | $2.78 | $3.17 | |
Diluted EPS (Cont. Ops) | $3.57 | $4.72 | $4.15 | $2.76 | $3.15 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $2.6B | $3B | $4.5B | $6.2B | $6.3B | |
Revenue (Reported) | $6.9B | $6.6B | $8.5B | $8.1B | $7.8B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $2.6B | $3B | $4.5B | $6.2B | $6.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $1.6B | $2.1B | $2B | $1.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $582M | $640M | $732M | $802M | $774M | |
Other Inc / (Exp) | $3M | $4M | $5M | $5M | $7M | |
Operating Expenses | $583M | $603M | $666M | $720M | $774M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $781M | $536M | $664M | $430M | $468M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $170M | $116M | $153M | $96M | $95M | |
Net Income to Company | $611M | $420M | $511M | $334M | $373M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $611M | $420M | $511M | $334M | $373M | |
Basic EPS (Cont. Ops) | $1.38 | $0.94 | $1.00 | $0.66 | $0.78 | |
Diluted EPS (Cont. Ops) | $1.37 | $0.93 | $1.00 | $0.65 | $0.77 | |
Weighted Average Basic Share | $426M | $422.4M | $485.4M | $461.4M | $438.3M | |
Weighted Average Diluted Share | $427.9M | $424.7M | $487.7M | $463.8M | $442.2M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $880M | $602M | $1.4B | $1.6B | $1.4B | |
Revenue (Reported) | $1.7B | $1.6B | $2.1B | $2B | $1.9B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $880M | $602M | $1.4B | $1.6B | $1.4B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $13B | $9.5B | $10.9B | $12B | $11.2B | |
Short Term Investments | $22.4B | $25.4B | $23.7B | $29.7B | $32.6B | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $39.3B | $37.7B | $36.9B | $43.3B | $45.3B | |
Property Plant And Equipment | $759M | $768M | $844M | $895M | $875M | |
Long-Term Investments | $25.5B | $27.6B | $33.5B | $38.6B | $41.1B | |
Goodwill | $7.1B | $7.1B | $8.2B | $8.2B | $8.2B | |
Other Intangibles | -- | $64M | $197M | $157M | $146M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $183.3B | $188.4B | $226.7B | $222B | $217.5B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $12M | $73M | $3M | $505M | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $243M | $74M | $3M | $505M | $2B | |
Long-Term Debt | $8.3B | $6.9B | $15.9B | $13.5B | $10.4B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $160.7B | $165B | $203B | $197.6B | $193.3B | |
Common Stock | $2B | $2B | $2B | $2B | $2.1B | |
Other Common Equity Adj | -$60M | -$665M | -$4.6B | -$3.8B | -$3.6B | |
Common Equity | $20.7B | $21.4B | $21.7B | $22.3B | $22.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $22.7B | $23.4B | $23.7B | $24.3B | $24.3B | |
Total Liabilities and Equity | $183.3B | $188.4B | $226.7B | $222B | $217.5B | |
Cash and Short Terms | $35.4B | $34.9B | $34.6B | $41.7B | $43.8B | |
Total Debt | $8.4B | $7B | $15.9B | $14B | $12.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $15B | $10.6B | $8.3B | $12B | $12.2B | |
Short Term Investments | $23.9B | $24.5B | $22.5B | $31.1B | $34.1B | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $41.9B | $38.2B | $32.8B | $43.6B | $47.1B | |
Property Plant And Equipment | $743M | $793M | $866M | $872M | $855M | |
Long-Term Investments | $26.8B | $26.4B | $32B | $40B | $42.5B | |
Goodwill | $7.1B | $7.2B | $8.2B | $8.2B | $8.2B | |
Other Intangibles | -- | -- | $185M | $148M | $137M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $187.2B | $192.1B | $222.3B | $220.4B | $220.1B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $70M | $25M | $1B | $9M | $47M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $70M | $25M | $1B | $1.3B | $2B | |
Long-Term Debt | $8.3B | $5.9B | $18.9B | $12.6B | $10.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $164.6B | $170B | $198.1B | $196.7B | $195.3B | |
Common Stock | $2B | $2B | $2B | $2B | $2.1B | |
Other Common Equity Adj | -$411M | -$2.3B | -$3.9B | -$4.2B | -$2.9B | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $22.7B | $22.1B | $24.2B | $23.8B | $24.9B | |
Total Liabilities and Equity | $187.2B | $192.1B | $222.3B | $220.4B | $220.1B | |
Cash and Short Terms | $38.9B | $35.1B | $30.8B | $43.1B | $46.3B | |
Total Debt | $8.4B | $5.9B | $19.9B | $13.8B | $12.3B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.1B | $2.3B | $2.1B | $1.6B | $1.5B | |
Depreciation & Amoritzation | $578M | $625M | $565M | $478M | $498M | |
Stock-Based Compensation | $48M | $59M | $84M | $87M | $97M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $111M | $2.3B | $4.1B | $3B | $2B | |
Capital Expenditures | $118M | $124M | $126M | $172M | $122M | |
Cash Acquisitions | -$3M | -$165M | -$255M | -- | -- | |
Cash From Investing | -$6.1B | -$10.5B | -$12.6B | $5.2B | $3B | |
Dividends Paid (Ex Special Dividend) | -$770M | -$783M | -$892M | -$928M | -$903M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $8.3B | -- | $24.6B | $26B | $13.2B | |
Long-Term Debt Repaid | -$14.1B | -$1.4B | -$19.7B | -$28.4B | -$14.3B | |
Repurchase of Common Stock | -$270M | -$545M | -$153M | -$906M | -$1.4B | |
Other Financing Activities | -$96M | -$23M | -$25M | $21M | $18M | |
Cash From Financing | $15.4B | $4.6B | $9.9B | -$7.1B | -$6B | |
Beginning Cash (CF) | $3.4B | $12.7B | $9.2B | $10.5B | $11.6B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $9.3B | -$3.6B | $1.4B | $1.1B | -$1B | |
Ending Cash (CF) | $12.7B | $9.2B | $10.5B | $11.6B | $10.6B | |
Levered Free Cash Flow | -$7M | $2.2B | $4B | $2.8B | $1.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $611M | $420M | $511M | $334M | $373M | |
Depreciation & Amoritzation | $152M | $67M | $118M | $102M | $123M | |
Stock-Based Compensation | $22M | $33M | $33M | $34M | $31M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$690M | $1.6B | $1.2B | $554M | -$213M | |
Capital Expenditures | $10M | $51M | $52M | $10M | $14M | |
Cash Acquisitions | -- | -$143M | -- | -- | -- | |
Cash From Investing | -$1.1B | -$3.9B | $1.5B | $1B | -$1.1B | |
Dividends Paid (Ex Special Dividend) | -$199M | -$198M | -$238M | -$228M | -$220M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $5.7B | $5.8B | $2.5B | |
Long-Term Debt Repaid | -$4M | -$1B | -$2.8B | -$5.4B | -$2.7B | |
Repurchase of Common Stock | -$95M | -- | -$400M | -$300M | -$200M | |
Other Financing Activities | -$22M | -$23M | -$24M | -$12M | -$24M | |
Cash From Financing | $3.7B | $3.1B | -$5.2B | -$1.6B | $2.3B | |
Beginning Cash (CF) | $12.7B | $9.2B | $10.5B | $11.6B | $10.6B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.9B | $778M | -$2.6B | -$29M | $940M | |
Ending Cash (CF) | $14.7B | $9.9B | $8B | $11.6B | $11.5B | |
Levered Free Cash Flow | -$700M | $1.5B | $1.1B | $544M | -$227M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.6B | $2.1B | $2.2B | $1.4B | $1.5B | |
Depreciation & Amoritzation | $526M | $540M | $616M | $462M | $519M | |
Stock-Based Compensation | $49M | $70M | $84M | $88M | $94M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $748M | $4.5B | $3.7B | $2.4B | $1.2B | |
Capital Expenditures | $112M | $165M | $127M | $130M | $126M | |
Cash Acquisitions | -- | -$308M | -$112M | -- | -- | |
Cash From Investing | $1.6B | -$13.3B | -$7.2B | $4.8B | $840M | |
Dividends Paid (Ex Special Dividend) | -$778M | -$782M | -$932M | -$918M | -$895M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $30.3B | $26B | $10B | |
Long-Term Debt Repaid | -$9.6B | -$2.4B | -$21.4B | -$31.1B | -$11.5B | |
Repurchase of Common Stock | -$95M | -- | -$553M | -$806M | -$1.3B | |
Other Financing Activities | -$104M | -$24M | -$26M | $33M | $6M | |
Cash From Financing | $8.3B | $4.1B | $1.6B | -$3.5B | -$2.1B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $10.6B | -$4.7B | -$2B | $3.6B | -$58M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $636M | $4.4B | $3.6B | $2.2B | $1.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $611M | $420M | $511M | $334M | $373M | |
Depreciation & Amoritzation | $152M | $67M | $118M | $102M | $123M | |
Stock-Based Compensation | $22M | $33M | $33M | $34M | $31M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$690M | $1.6B | $1.2B | $554M | -$213M | |
Capital Expenditures | $10M | $51M | $52M | $10M | $14M | |
Cash Acquisitions | -- | -$143M | -- | -- | -- | |
Cash From Investing | -$1.1B | -$3.9B | $1.5B | $1B | -$1.1B | |
Dividends Paid (Ex Special Dividend) | -$199M | -$198M | -$238M | -$228M | -$220M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $5.7B | $5.8B | $2.5B | |
Long-Term Debt Repaid | -$4M | -$1B | -$2.8B | -$5.4B | -$2.7B | |
Repurchase of Common Stock | -$95M | -- | -$400M | -$300M | -$200M | |
Other Financing Activities | -$22M | -$23M | -$24M | -$12M | -$24M | |
Cash From Financing | $3.7B | $3.1B | -$5.2B | -$1.6B | $2.3B | |
Beginning Cash (CF) | $12.7B | $9.2B | $10.5B | $11.6B | $10.6B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.9B | $778M | -$2.6B | -$29M | $940M | |
Ending Cash (CF) | $14.7B | $9.9B | $8B | $11.6B | $11.5B | |
Levered Free Cash Flow | -$700M | $1.5B | $1.1B | $544M | -$227M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.